Article
Structural modeling of p.V31F variant in the aspartoacylase gene.
Metabolic brain disease - 1 Jun 2016
Krishnamoorthy Navaneethakrishnan, Zayed Hatem
Abstract excerpt
Aspartoacylase (ASPA) is an abundant enzyme in the brain, which catalyzes the conversion of N-acetylaspartate into acetate and aspartate, deficiency in its activity leads to degeneration of the white matter of the brain and is a recognized cause of Canavan disease (CD), which affect children. Although genotype-phenotype correlation have been reported for Canavan disease patients, this relationships is still not...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
